Yahoo Web Search

Search results

1. • 

     Pipeline Moves: Investigator-led trial of Lilly’s merestinib in solid tumours terminated

     Clinical Trials Arena via Yahoo Finance· 7 hours ago

     This week on Pipeline Moves, we kick off by looking at the termination of a Phase II...

2. • 

     New Trials in Prostate Cancer: Could Your Patient Benefit?

     Medscape· 10 hours ago

     Perhaps one of your patients could benefit from a clinical trial that has recently opened in...

3. • PGE2 inhibits TIL expansion by disrupting IL-2 signalling and mitochondrial function - Nature

     Nature· 5 days ago

     Prostaglandin E2 from the tumour microenvironment impairs interleukin-2 sensing by tumour-infiltrating lymphocytes, restricting proliferative response and promoting T cell death via metabolic impairment and ferroptosis.

4. • 

     Lenire from Neuromod delivers tinnitus improvement 'not demonstrated for any other treatment,'...

     FOX 59 Indianapolis· 8 hours ago

     'Textbook of Tinnitus' is a comprehensive textbook that describes tinnitus, how it is caused, and...

5. • 

     Increasing T-Cell Survival To Improve Cancer Immunotherapy

     Technology Networks· 7 days ago

     In the past decade, immunotherapy has emerged as the fourth pillar of cancer treatment, joining...

6. • 

     What Happened to Aspirin? And What Replaces It?

     Medscape· 5 days ago

     As the pendulum has swung against recommending aspirin for the primary prevention of heart attacks and strokes, clinicians should focus on other ways to...

7. • 

     NIH Reports Lower Dose of Mpox Vaccine is Safe and Generates Six-Week Antibody Response Equivalent...

     Sierra Sun Times· 1 day ago

     A dose-sparing intradermal mpox vaccination regimen was safe and generated an antibody response...

8. • Small Business - Cordele Dispatch | Cordele Dispatch

     Cordele Dispatch· 3 hours ago

     Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced the acceptance of an ...

9. • 

     Aclarion's Nociscan Solution to Play Key Role in Groundbreaking LIFEHAB Trial Evaluating the...

     NewMediaWire via Yahoo Finance· 4 days ago

     LIFEHAB is a randomized controlled trial in Norway comparing lumbar interbody fusion surgery with...

10. • 

      Colorado enacts groundbreaking brain data privacy law

      FOX 10 Phoenix· 5 days ago

      Marco Baptista, Chief Scientific Officer with the Christopher & Dana Reeve Foundation, joins...